Cleveland Research

Cleveland Research initiated coverage on Alcoa Inc (NYSE: AA) Wednesday with a Neutral rating. Analysts Christopher D. Olin and Casey McDonald had a “favorable long-term view of the company, mitigated by potential FY15 aluminum-related headwinds.” Olin was not confident, however,...

Shares of Facebook Inc (NASDAQ: FB) were trading higher on Tuesday. Kevin Rottinghaus of Cleveland Research initiated coverage of the company with a Buy rating and $100 price target. According to Rottinghaus, Facebook has "significant runway" to gain market share within the digital advertising...

Cleveland Research downgraded United Natural Foods, Inc. (NASDAQ: UNFI) from Buy to Neutral. United Natural Foods shares have gained 1.84 percent over the past 52 weeks, while the S&P 500 index has gained 11.18 percent in the same period. United Natural Foods shares closed at $70.31 on Friday.

Analysts at Cleveland Research downgraded WESCO International, Inc. (NYSE: WCC) from Buy to Neutral. WESCO International shares have dropped 19.24 percent over the past 52 weeks, while the S&P 500 index has gained 11.18 percent in the same period. Wesco International shares closed at $69.42...

Cleveland Research commented on Advance Auto Parts, Inc. (NYSE: AAP) Wednesday and said that integration disruptions were becoming a bigger concern. Analysts led by Daryl Boehringer felt that merger-related disruption had lead to a "wider degree of underperformance" and that channel...

Micron Technology, Inc. (NASDAQ: MU) is faced with continued pricing problems and may offer results in a release slated for April 2, an analyst said Tuesday. Micron, off 23 percent since December, traded recently at $27.68, down 3 percent. Cleveland Research's Kevin Rottinghaus said the Boise,...

On Tuesday, Matthew Delly of Cleveland Research stated that J C Penney Company Inc's (NYSE: JCP) challenging sales trends which were pre-announced in September continued into October. In a note to clients, Delly states that J C Penney's challenging traffic trends is "likely driven...

Shares of Insys Therapeutics (NASDAQ: INSY) dropped 10 percent Thursday. The company experienced selling pressure as news hit that Cleveland Research showed that both Express Scripts and CVS will be reviewing new drug debuts on a quarterly basis. The research report noted that Insys...

Cleveland Research commented on retail department stores sales in notes this week. Despite the firm's optimism on J.C. Penney's (NYSE: JCP) second quarter, Kohl's (NYSE: KSS) is facing near-term headwinds from soft sales. Analyst Matthew Delly reported that Kohl's sales are...

Shares of J.C. Penney (NYSE: JCP) jumped 4.4 percent following analyst optimism on second quarter results. Cleveland Research reported that they expect the company's second quarter sales trends to remain positive. The analyst highlighted that J.C. Penney's re-focus on private label...

In a report published Monday, Cleveland Research analyst Matthew Delly noted that J.C. Penney (NYSE: JCP) is well-positioned to increase promotional activity. Delly remarked, "J.C. Penney looks positioned to increase the frequency and depth of promotional activity during 1H." The analyst...

Cleveland Research analyst Benjamin Bollin commented that Apple's (NASDAQ: AAPL) second quarter is "off to a slow start". Bollin reported that for near-term outlook, China Mobile may not be a "significant iPhone volume catalyst" due to the company's pricing and competition with China Unicom and...

Cleveland Research analyst Daryl Boehringer raised estimates on Best Buy Co., Inc. (NYSE: BBY) assuming market share gains in earnings report next week. Boehringer commented on Best Buy's improved comp/ margin trajectory, ongoing cost savings, and upcoming product introductions tailwinds....